Log In
Print this Print this

RG7916, RO7034067

  Manage Alerts
Collapse Summary General Information
Company PTC Therapeutics Inc.
DescriptionSurvival of motor neuron 2 centromeric (SMN2) splicing modifier
Molecular Target Survival of motor neuron 2 centromeric (SMN2)
Mechanism of Action 
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today